311 related articles for article (PubMed ID: 32221022)
1. Effectiveness of CO
Angioli R; Stefano S; Filippini M; Pieralli A; Montera R; Plotti F; Gatti A; Bartolone M; Luvero D
Int J Gynecol Cancer; 2020 May; 30(5):590-595. PubMed ID: 32221022
[TBL] [Abstract][Full Text] [Related]
2. Fractional microablative CO2 laser for vulvovaginal atrophy in women treated with chemotherapy and/or hormonal therapy for breast cancer: a retrospective study.
Pagano T; De Rosa P; Vallone R; Schettini F; Arpino G; De Placido S; Nazzaro G; Locci M; De Placido G
Menopause; 2016 Oct; 23(10):1108-13. PubMed ID: 27648595
[TBL] [Abstract][Full Text] [Related]
3. Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors.
Pieralli A; Fallani MG; Becorpi A; Bianchi C; Corioni S; Longinotti M; Tredici Z; Guaschino S
Arch Gynecol Obstet; 2016 Oct; 294(4):841-6. PubMed ID: 27170261
[TBL] [Abstract][Full Text] [Related]
4. Sexual function after fractional microablative CO₂ laser in women with vulvovaginal atrophy.
Salvatore S; Nappi RE; Parma M; Chionna R; Lagona F; Zerbinati N; Ferrero S; Origoni M; Candiani M; Leone Roberti Maggiore U
Climacteric; 2015 Apr; 18(2):219-25. PubMed ID: 25333211
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study.
Filippini M; Luvero D; Salvatore S; Pieralli A; Montera R; Plotti F; Candiani M; Angioli R
Menopause; 2020 Jan; 27(1):43-49. PubMed ID: 31794500
[TBL] [Abstract][Full Text] [Related]
6. Short-Term Efficacy and Safety of Non-Ablative Laser Treatment Alone or with Estriol or Moisturizers in Postmenopausal Women with Vulvovaginal Atrophy.
Alvisi S; Lami A; Baldassarre M; Lenzi J; Mancini I; Seracchioli R; Meriggiola MC
J Sex Med; 2022 May; 19(5):761-770. PubMed ID: 35370104
[TBL] [Abstract][Full Text] [Related]
7. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study.
Salvatore S; Nappi RE; Zerbinati N; Calligaro A; Ferrero S; Origoni M; Candiani M; Leone Roberti Maggiore U
Climacteric; 2014 Aug; 17(4):363-9. PubMed ID: 24605832
[TBL] [Abstract][Full Text] [Related]
8. CO
Salvatore S; Pitsouni E; Grigoriadis T; Zacharakis D; Pantaleo G; Candiani M; Athanasiou S
Climacteric; 2021 Apr; 24(2):187-193. PubMed ID: 33089713
[TBL] [Abstract][Full Text] [Related]
9. Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study.
Pagano T; De Rosa P; Vallone R; Schettini F; Arpino G; Giuliano M; Lauria R; De Santo I; Conforti A; Gallo A; Nazzaro G; De Placido S; Locci M; De Placido G
Menopause; 2018 Jun; 25(6):657-662. PubMed ID: 29286986
[TBL] [Abstract][Full Text] [Related]
10. [Short-term efficacy of vaginal CO
Kozma B; Póka R; Sipos A; Ács N; Takács P
Orv Hetil; 2019 Oct; 160(41):1617-1622. PubMed ID: 31587579
[TBL] [Abstract][Full Text] [Related]
11. The Fractional CO
Li J; Li H; Zhou Y; Xie M; Miao Y; Wang L; Zhao Y; Ying T; Hu Y; Chen Y; Chen Y; Sun X; Wang J
Lasers Surg Med; 2021 Jul; 53(5):647-653. PubMed ID: 33211334
[TBL] [Abstract][Full Text] [Related]
12. Use of a novel fractional CO2 laser for the treatment of genitourinary syndrome of menopause: 1-year outcomes.
Sokol ER; Karram MM
Menopause; 2017 Jul; 24(7):810-814. PubMed ID: 28169913
[TBL] [Abstract][Full Text] [Related]
13. Rationale and design for fractional microablative CO
Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
[TBL] [Abstract][Full Text] [Related]
14. [How I do? a treatment with fractional CO
Jardin I; Louis-Vahdat C; Canlorbe G; Mergui JL; Uzan C; Azaïs H
Gynecol Obstet Fertil Senol; 2018 Nov; 46(10-11):735-739. PubMed ID: 30266539
[No Abstract] [Full Text] [Related]
15. Does the Time of Onset of Urinary Symptoms Affect Microablative Fractional CO
Ruffolo AF; Casiraghi A; Marotta E; Degliuomini R; Parma M; Athanasiou S; Benini V; Candiani M; Salvatore S
Lasers Surg Med; 2021 Sep; 53(7):953-959. PubMed ID: 33476052
[TBL] [Abstract][Full Text] [Related]
16. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial.
Paraiso MFR; Ferrando CA; Sokol ER; Rardin CR; Matthews CA; Karram MM; Iglesia CB
Menopause; 2020 Jan; 27(1):50-56. PubMed ID: 31574047
[TBL] [Abstract][Full Text] [Related]
17. Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors.
Quick AM; Zvinovski F; Hudson C; Hundley A; Evans C; Suresh A; Stephens JA; Arthur E; Ramaswamy B; Reinbolt RE; Noonan AM; VanDeusen JB; Wesolowski R; Stover DG; Williams NO; Sardesai SD; Smith KL; Faubion SS; Loprinzi CL; Lustberg MB
Support Care Cancer; 2020 Aug; 28(8):3669-3677. PubMed ID: 31811486
[TBL] [Abstract][Full Text] [Related]
18. Vaginal CO
Pearson A; Booker A; Tio M; Marx G
Breast Cancer Res Treat; 2019 Nov; 178(1):135-140. PubMed ID: 31377895
[TBL] [Abstract][Full Text] [Related]
19. Microablative fractional CO
Pitsouni E; Grigoriadis T; Tsiveleka A; Zacharakis D; Salvatore S; Athanasiou S
Maturitas; 2016 Dec; 94():131-136. PubMed ID: 27823733
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]